
|Articles|December 1, 2001
Policy changes offer steady AK coverage but diminished reimbursement
The destruction of benign, malignant, and premalignant lesions has been and continues to be the main income stream for most dermatologists in private practice.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma
5











